相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) plus Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032
Alice L. Yu et al.
CLINICAL CANCER RESEARCH (2021)
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma
Elizabeth C. Lewis et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
Lucas Moreno et al.
EUROPEAN JOURNAL OF CANCER (2020)
Biochemical features of primary cells from a pediatric patient with a gain-of-function ODC1 genetic mutation
Chad R. Schultz et al.
BIOCHEMICAL JOURNAL (2019)
Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models
Thinh H. Nguyen et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma
Chad R. Schultz et al.
BIOCHEMICAL JOURNAL (2018)
The Expanding World of N-MYC-Driven Tumors
David S. Rickman et al.
CANCER DISCOVERY (2018)
Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study
Jessica Alber et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Novel de novo pathogenic variant in the ODC1 gene in a girl with developmental delay, alopecia, and dysmorphic features
Caleb P. Bupp et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)
Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide
G. Latkovskis et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Polyamine synthesis as a target of MYC oncogenes
Andre S. Bachmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Polyamine metabolism and cancer: treatments, challenges and opportunities
Robert A. Casero et al.
NATURE REVIEWS CANCER (2018)
Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib
Maria M. Posada et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Repositioning of drugs using open-access data portal DTome: A test case with probenecid (Review)
Mohammad U. Ahmed et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Functions of Polyamines in Mammals
Anthony E. Pegg
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Renal drug transporters and their significance in drug-drug interactions
Jia Yin et al.
ACTA PHARMACEUTICA SINICA B (2016)
Combinations of beta-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection
Joaquin Rullas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
Giselle L. Saulnier Sholler et al.
PLOS ONE (2015)
Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma
Ann M. Lozier et al.
ONCOTARGET (2015)
Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Medecins Sans Frontieres Experience in the Democratic Republic of the Congo
Emilie Alirol et al.
CLINICAL INFECTIOUS DISEASES (2013)
AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport
Katherine Samal et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma
Dana-Lynn T. Koomoa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
MYCN oncoprotein targets and their therapeutic potential
Emma Bell et al.
CANCER LETTERS (2010)
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification
Dirk Geerts et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
Robert J. Rounbehler et al.
CANCER RESEARCH (2009)
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto et al.
LANCET (2009)
Pharmacokinetics and tolerability of oseltamivir combined with probenecid
Mark Holodniy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Ornithine Decarboxylase Inhibition by α-Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in Neuroblastoma
Dana-Lynn T. Koomoa et al.
CANCER RESEARCH (2008)
ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
Michael D. Hogarty et al.
CANCER RESEARCH (2008)
Medical treatment of hirsutism
Ulrike Blume-Peytavi et al.
DERMATOLOGIC THERAPY (2008)
The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism
Joseph Jackson et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)
Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis
O. Heby et al.
AMINO ACIDS (2007)
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
Robert A. Casero et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Polyamines and neoplastic growth
A. E. Pegg et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells
CJ Wallick et al.
ONCOGENE (2005)
Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation
JA Nilsson et al.
CANCER CELL (2005)
Polyamines and cancer: Old molecules, new understanding
EW Gerner et al.
NATURE REVIEWS CANCER (2004)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
分享论文
